title: Successful Anticoagulation Using Argatroban During Transcatheter Aortic Valve Implantation in a Patient With Heparin-Induced Thrombocytopenia.
abstract: We report the first case of transfemoral transcatheter aortic valve implantation with a history of heparin-induced thrombocytopenia that was successfully managed with perioperative argatroban.
authors: From the Departments of *Cardiology and †Anesthesiology, New Tokyo Hospital, Chiba, Japan.
authors: Toru
authors: T
authors: Naganuma
authors: Satoru
authors: S
authors: Mitomo
authors: Nobuhide
authors: N
authors: Kin
authors: Sunao
authors: S
authors: Nakamura
mesh_terms: D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010875:Pipecolic Acids / Q000627:therapeutic use*; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D065467:Transcatheter Aortic Valve Replacement / Q000379:methods*
chemical_list: D000925:Anticoagulants; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban